Should the Food and Drug Administration warning of malignancy in children receiving tumor necrosis factor alpha blockers change the way we treat children with juvenile idiopathic arthritis?
- PMID: 20506203
- DOI: 10.1002/art.27506
Should the Food and Drug Administration warning of malignancy in children receiving tumor necrosis factor alpha blockers change the way we treat children with juvenile idiopathic arthritis?
Comment on
-
Tumor necrosis factor alpha blockers and malignancy in children: forty-eight cases reported to the Food and Drug Administration.Arthritis Rheum. 2010 Aug;62(8):2517-24. doi: 10.1002/art.27511. Arthritis Rheum. 2010. PMID: 20506368
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical